A tale of two drug testing technologies: GC-MS and LC-MS/MS

Pain Physician

Volumn 13, Issue 1, 2010, Pages 91-92

  Mikel, Charles ^a   Pesce, Amadeo ^a   West, Cameron ^a  

^a Millennium Laboratories Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CANNABINOID DERIVATIVE; FENTANYL; OPIATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

DIAGNOSTIC PROCEDURE; DRUG COMPETITION; DRUG SCREENING; LABORATORY TEST; LETTER; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; POLYPHARMACY; URINALYSIS;

CHROMATOGRAPHY, LIQUID; FALSE POSITIVE REACTIONS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; URINALYSIS;

EID: 76149137739     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Mandatory Guidelines for Federal Workplace Drug Testing Programs: Notice. Federal Register, 73:228.
2. Wu A, Ostheimer D, Cremese M, Forte E, Hill D. Characterization of drug interferences caused by coelution of substances in gas chromatography/mass spectrometry confi rmation of targeted drugs in full-scan and selected-ion modes. Clin Chem 1994; 40:216-220.
3. Manchikanti L, Damron KS, McManus CD, Barnhill RC. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: A prospective, observational study. Pain Physician 2004; 7:431-437.
4. Mikel C, Pesce A, West C, Crews B, West R, Latyshev S, Almazan P. LC-MS/MS Extends the range of drug quantitation. Therapeutic drug monitoring. In Press.
5. Wooten J, Galavis J. Polypharma cy: Keeping the elderly safe. Modern Medicine http://rn.modernmedicine.com/rnweb/article/articleDetail.jsp?id= 172920. Published online 2005.